Title : Significance of ER-Src axis in hormonal therapy resistance.

Pub. Date : 2011 Nov

PMID : 21184269






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pharmacological inhibition of Src using dasatinib, an orally available inhibitor substantially inhibited the growth of therapy resistant MCF7-PELP1, MCF7-HER2, and MCF7-Tam model cells in proliferation assays. Dasatinib proline, glutamate and leucine rich protein 1 Homo sapiens
2 Combinatorial therapy of tamoxifen with dasatinib showed better therapeutic effect compared to single agent therapy on the growth of therapy resistant PELP1 driven tumors. Tamoxifen proline, glutamate and leucine rich protein 1 Homo sapiens
3 Combinatorial therapy of tamoxifen with dasatinib showed better therapeutic effect compared to single agent therapy on the growth of therapy resistant PELP1 driven tumors. Dasatinib proline, glutamate and leucine rich protein 1 Homo sapiens
4 Since PELP1, HER2, and Src kinase are commonly deregulated in breast cancers, combination therapies using both endocrine agents and dasatinib may have better therapeutic effect by delaying the development of hormonal resistance. Dasatinib proline, glutamate and leucine rich protein 1 Homo sapiens